|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 12616 |
FusionGeneSummary for FAM162A_CSTA |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FAM162A_CSTA | Fusion gene ID: 12616 | Hgene | Tgene | Gene symbol | FAM162A | CSTA | Gene ID | 26355 | 1475 |
| Gene name | family with sequence similarity 162 member A | cystatin A | |
| Synonyms | C3orf28|E2IG5|HGTD-P | AREI|PSS4|STF1|STFA | |
| Cytomap | 3q21.1 | 3q21.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein FAM162AE2-induced gene 5 proteinHIF-1 alpha-responsive proapoptotic moleculegrowth and transformation-dependent protein | cystatin-Acystatin A (stefin A)cystatin AS | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q96A26 | P01040 | |
| Ensembl transtripts involved in fusion gene | ENST00000232125, ENST00000477892, ENST00000469967, | ENST00000264474, ENST00000479204, | |
| Fusion gene scores | * DoF score | 3 X 2 X 5=30 | 7 X 6 X 4=168 |
| # samples | 5 | 7 | |
| ** MAII score | log2(5/30*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/168*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: FAM162A [Title/Abstract] AND CSTA [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | FAM162A | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 15082785 |
| Hgene | FAM162A | GO:0043065 | positive regulation of apoptotic process | 15082785 |
| Hgene | FAM162A | GO:0071456 | cellular response to hypoxia | 15082785 |
| Hgene | FAM162A | GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 15082785 |
| Tgene | CSTA | GO:0010466 | negative regulation of peptidase activity | 6203523 |
| Tgene | CSTA | GO:0018149 | peptide cross-linking | 10908733 |
| Tgene | CSTA | GO:0030216 | keratinocyte differentiation | 10908733 |
| Tgene | CSTA | GO:0045861 | negative regulation of proteolysis | 3488317 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | PRAD | TCGA-G9-A9S4-01A | FAM162A | chr3 | 122103146 | + | CSTA | chr3 | 122044109 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-5UTR | ENST00000232125 | ENST00000264474 | FAM162A | chr3 | 122103146 | + | CSTA | chr3 | 122044109 | + |
| 5UTR-5UTR | ENST00000232125 | ENST00000479204 | FAM162A | chr3 | 122103146 | + | CSTA | chr3 | 122044109 | + |
| 5CDS-5UTR | ENST00000477892 | ENST00000264474 | FAM162A | chr3 | 122103146 | + | CSTA | chr3 | 122044109 | + |
| 5CDS-5UTR | ENST00000477892 | ENST00000479204 | FAM162A | chr3 | 122103146 | + | CSTA | chr3 | 122044109 | + |
| 5CDS-5UTR | ENST00000469967 | ENST00000264474 | FAM162A | chr3 | 122103146 | + | CSTA | chr3 | 122044109 | + |
| 5CDS-5UTR | ENST00000469967 | ENST00000479204 | FAM162A | chr3 | 122103146 | + | CSTA | chr3 | 122044109 | + |
Top |
FusionProtFeatures for FAM162A_CSTA |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FAM162A | CSTA |
| Proposed to be involved in regulation of apoptosis; theexact mechanism may differ between cell types/tissues. May beinvolved in hypoxia-induced cell death of transformed cellsimplicating cytochrome C release and caspase activation (such asCASP9) and inducing mitochondrial permeability transition. May beinvolved in hypoxia-induced cell death of neuronal cells probablyby promoting release of AIFM1 from mitochondria to cytoplasm andits translocation to the nucleus; however, the involvement ofcaspases has been reported conflictingly.{ECO:0000269|PubMed:15082785}. | This is an intracellular thiol proteinase inhibitor. Hasan important role in desmosome-mediated cell-cell adhesion in thelower levels of the epidermis. {ECO:0000269|PubMed:21944047}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FAM162A_CSTA |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FAM162A_CSTA |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| FAM162A | SRRT, SLC25A1, PTRF, VDAC2, MRPL22, RMDN3, TM9SF4, TIMM23B, SSR3, HACL1, IWS1, UBL4A, HSP90AA1, ADRB2, BSG, SIAE, CPVL, NDUFA4, ASPH, GHITM, CTNNA3, PCDHA12 | CSTA | CTSB, CTSL, CTSH, PI3, KRT1, LOR, DSP, IVL, CSTA, USP53, UCHL5, RAD21, TCF3, CUL4B, CUL2, CDK2, METTL23, CEP57, ZDHHC17, TCTN3, RASSF9, RASSF10, HERC2, FOXR1, MCM2, EGFR, ZIC1, CYLD |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FAM162A_CSTA |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for FAM162A_CSTA |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | CSTA | C0017636 | Glioblastoma | 1 | CTD_human |
| Tgene | CSTA | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
| Tgene | CSTA | C2931822 | Nasopharyngeal carcinoma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|